Value or desirability of hemorheological-hemostatic parameter changes as endpoints in blood lipid-regulating trials.


High levels of plasma lipids have been recognized as a major risk factor in the development and progression of atherosclerosis, and to influence hemorheological factors that may predispose to thrombotic complications. Lipid-lowering interventions have been associated with a significant reduction of morbidity and mortality. Several mechanisms have been… (More)


  • Presentations referencing similar topics